XML 21 R5.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Restructuring Liability [Member]
Additional Paid-in Capital [Member]
Restructuring Liability [Member]
Side Warrants [Member]
Additional Paid-in Capital [Member]
Side Warrants [Member]
Note Conversion Warrants
Common Stock
Note Conversion Warrants
Additional Paid-in Capital [Member]
Note Conversion Warrants
Note Default [Member]
Additional Paid-in Capital [Member]
Note Default [Member]
Preferred Stock [Member]
Preferred Stock [Member]
Preferred Stock [Member]
Common Stock
Common Stock
Common Stock
Additional Paid-in Capital [Member]
Common Stock
Additional Paid-in Capital [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Common Stock
Preferred Stock [Member]
Total
Balance at beginning of period at Dec. 31, 2016                     $ 8   $ 4     $ 4,376 $ (10,848)     $ (6,460)
Balance at beginning of period (in shares) at Dec. 31, 2016                     780,105   449,175              
Increase (Decrease) in Stockholders' Equity                                        
Net loss                                 (20,694)     (20,694)
Conversion of warrants into stock                       $ 20   $ (20) $ 25       $ 25  
Conversion of warrants into stock (in shares)                   8,542   1,958,166                
Shares converted, value                     $ (25)   $ 42     (17)        
Conversion of preferred stock into common stock (in shares)                     (2,527,879)   4,217,408              
Conversion of debt into stock         $ 6 $ 2,732 $ 2,738       $ 8   $ 14     4,749       4,771
Conversion of debt into stock (in shares)         515,638           802,920   1,414,700              
Issuance of common stock for consulting services in connection with the merger                         $ 3     2,186       2,189
Issuance of common stock for consulting services in connection with the merger (in shares)                         321,821              
Shares issued in connection with business combination                     $ 8   $ 12     20,078       20,098
Shares issued in connection with business combination (in shares)                     802,925   1,255,119              
Issuance of preferred stock                     $ 1         7,783       7,784
Issuance of preferred stock (in shares)                     138,322                  
Issuance of warrants in conjunction with issuance of side agreement $ 159 $ 159 $ 487 $ 487       $ 15 $ 15                      
Beneficial conversion feature on issuance of notes                               1,856       1,856
Non-cash stock-based compensation and vesting of restricted units                         $ 1     56       57
Non-cash stock-based compensation and vesting of restricted units (in shares)                         64,593              
Balance at end of period at Dec. 31, 2017                         $ 102     44,465 (31,542)     13,025
Balance at end of period (in shares) at Dec. 31, 2017                     4,935   10,196,620              
Increase (Decrease) in Stockholders' Equity                                        
Net loss                                 (15,694)     (15,694)
Shares converted, value                         $ 65     (65)        
Conversion of preferred stock into common stock (in shares)                     (4,888)   6,465,334              
Conversion of debt into stock                       $ 58   $ 2,298       $ 2,356    
Conversion of debt into stock (in shares)                       5,773,439           3,787,300    
Issuance of common stock in connection with purchase agreements                         $ 64     1,944       2,008
Issuance of common stock in connection with purchase agreements (in shares)                         6,420,723              
Issuance of common stock in exchange for cancelation of other current liabilities                         $ 18     1,879       1,897
Issuance of common stock in exchange for cancelation of other current liabilities (in shares)                         1,814,754              
Issuance of common stock upon exercise of warrants                         $ 38     1,233       1,271
Issuance of common stock upon exercise of warrants (in shares)                         3,787,300              
Issuance of common stock for consulting services in connection with the merger                               39       39
Issuance of common stock for consulting services in connection with the merger (in shares)                         22,913              
Warrant modification recorded as debt discount in conjunction with convertible note issuance                               11       11
Beneficial conversion feature on issuance of notes                               2,118       2,118
Write-off beneficial conversion feature in conjunction with convertible note extinguishment                               (1,029)       (1,029)
Write-off debt discounts (net of debt premiums) in conjunction with convertible note conversions                               (210)       (210)
Write-off debt derivative liability in conjunction with convertible note conversions                               301       301
Liability recorded related to equity purchase agreement repricing                                 (460)     (460)
Non-cash stock-based compensation and vesting of restricted units                               490       490
Balance at end of period at Dec. 31, 2018                         $ 345     $ 53,474 $ (47,696)     $ 6,123
Balance at end of period (in shares) at Dec. 31, 2018                     47   34,481,083